Human papillomavirus vaccination

Obstetrics and Gynecology

Volumn 108, Issue 3 I, 2006, Pages 699-705

[No Author Info available]

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS VACCINE;

BREAST FEEDING EDUCATION; CONDYLOMA; HUMAN; IMMUNE DEFICIENCY; INFECTION PREVENTION; PATIENT EDUCATION; PRIORITY JOURNAL; REVIEW; SCREENING; SEXUAL BEHAVIOR; SEXUALLY TRANSMITTED DISEASE; UNITED STATES; UTERINE CERVIX CANCER; UTERINE CERVIX CARCINOMA IN SITU; UTERINE CERVIX CYTOLOGY; VACCINATION; VIRUS INFECTION; WART VIRUS; WOMEN'S HEALTH;

EID: 33748355353     PISSN: 00297844     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (28)

1. Human papillomavirus. ACOG Practice Bulletin No. 61. American College of Obstetricians and Gynecologists. Obstet Gynecol 2005;105:905-18.
2. Bosch FX, Manos MM, Munoz N, Sherman M, Jansen AM, Peto J, et al. Prevalence of human papillomavirus in cervical cancer: a worldwide perspective. International biological study on cervical cancer (IBSCC) Study Group. J Natl Cancer Inst 1995;87:796-802.
3. American Cancer Society. Cancer facts and figures 2006. Atlanta (GA): ACS; 2006. Available at: http://www.cancer.org/downloads/STT/CAFF2006PWSecured. pdf. Retrieved June 29, 2006.
4. World Health Organization. State of the art new vaccines: research and development. Initiative for Vaccine Research. Geneva: WHO; 2003. Available at: http://www.who.int/vaccine_research/documents/en/stateofart_excler.pdf. Retrieved November 21, 2003.
5. International Agency for Research on Cancer. GLOBO-CAN 2002 database. Lyon (FR): IARC; 2002.
6. Parkin DM, Pisani P, Ferlay J. Estimates of the worldwide incidence of eighteen major cancers in 1985. Int J Cancer 1993;54:594-606.
7. National Center for Health Statistics. Health, United States, 2005 with chartbook on trends in the health of Americans. Hyattsville (MD): NCHS; 2005.
8. Prescribing information for GARDASIL. Whitehouse Station (NJ): Merck & Co., Inc.; 2006. Available at: http://www.merck.com/product/usa/ pi_circulars/g/gardasil/gardasil_pi.pdf. Retrieved June 26, 2006.
9. Centers for Disease Control and Prevention. HPV and HPV vaccine - information for healthcare providers. Available at: http://www.cdc.gov/std/HPV/ STDFact-HPVvaccine-hcp.htm#hpvvaccine. Retrieved July 7, 2006.
10. Harper DM, Franco EL, Wheeler C, Ferris DG, Jenkins D, Schuind A, et al. Efficacy of a bivalent L1 virus-like particle vaccine in prevention of infection with human papillomavirus types 16 and 18 in young women: a randomised controlled trial. GlaxoSmithKline HPV Vaccine Study Group. Lancet 2004;364:1757-65.
11. Harper DM, Franco EL, Wheeler CM, Moscicki AB, Romanowski B, Roteli-Martins CM, et al. Sustained efficacy up to 4.5 years of a bivalent L1 virus-like particle vaccine against human papillomavirus types 16 and 18: follow-up from a randomised control trial. Lancet 2006;367:1247-55.
12. Mao C, Koutsky LA, Ault KA, Wheeler CM, Brown DR, Wiley DJ, et al. Efficacy of human papillomavirus-16 vaccine to prevent cervical intraepithelial neoplasia: a randomized controlled trial [published erratum appears in Obstet Gynecol 2006;107:1425]. Obstet Gynecol 2006;107:18-27.
13. Centers for Disease Control and Prevention. HPV vaccine [human papillomavirus (HPV) and the HPV vaccine]. Atlanta (GA): CDC. Available at: http://www.cdc.gov/nip/vaccine/hpv/. Retrieved July 26, 2006.
14. American College of Obstetricians and Gynecologists. Primary and preventive health care for female adolescents. In: Health care for adolescents. Washington, DC: ACOG; 2003. p. 1-24.
15. Evaluation and management of abnormal cervical cytology and histology in the adolescent. ACOG Committee Opinion No. 330. American College of Obstetricians and Gynecologists. Obstet Gynecol 2006:107:963-8.
16. Cervical cancer screening in adolescents. ACOG Committee Opinion No. 300. American College of Obstetricians and Gynecologists. Obstet Gynecol 2004;104:885-9.
17. Cervical cytology screening. ACOG Practice Bulletin No. 45. American College of Obstetricians and Gynecologists. Obstet Gynecol 2003;102:417-27.
18. Moscicki AB, Shiboski S, Broering J, Powell K, Clayton L, Jay N, et al. The natural history of human papillomavirus infection as measured by repeated DNA testing in adolescent and young women. J Pediatr 1998;132:277-84.
19. Atkinson WL, Pickering LK, Schwartz B, Weniger BG, Iskander JK, Watson JC. General recommendations on immunization. Recommendations of the Advisory Committee on Immunization Practices (ACIP) and the American Academy of Family Physicians (AAFP). Centers for Disease Control and Prevention. MMWR Recomm Rep 2002;51(RR-2):1-35.
20. Hogewoning CJ, Bleeker MC, van den Brule AJ, Voorhorst FJ, Snijders PJ, Berkhof J, et al. Condom use promotes regression of cervical intraepithelial neoplasia and clearance of human papillomavirus: a randomized clinical trial. Int J Cancer 2003;107:811-6.
21. Winer RL, Hughes JP, Feng Q, O'Reilly S, Kiviat NB, Holmes KK, et al. Condom use and the risk of genital human papillomavirus infection in young women. N Engl J Med 2006;354:2645-54.
22. Zimet GD, Mays RM, Winston Y, Kee R, Dickes J, Su L. Acceptability of human papillomavirus immunization. J Womens Health Gend Based Med 2000;9:47-50.
23. Lazcano-Ponce E, Rivera L, Arillo-Santillan E, Salmeron J, Hernandez-Avila M, Munoz N. Acceptability of a human papillomavirus (HPV) trial vaccine among mothers of adolescents in Cuernavaca, Mexico. Arch Med Res 2001;32:243-7.
24. Hoover DR, Carfioli B, Moench EA. Attitudes of adolescent/young adult women toward human papillomavirus vaccination and clinical trials. Health Care Women Int 2000;21:375-91.
25. Davis K, Dickman ED, Ferris D, Dias JK. Human papillomavirus vaccine acceptability among parents of 10- to 15-year-old adolescents. J Low Genit Tract Dis 2004;8:188-94.
26. Centers for Disease Control and Prevention. The guide to community preventive services. Effectiveness of multicomponent interventions that include education to increase vaccination coverage. Atlanta (GA): CDC; 2003. Available at: http://www.thecommunityguide.org/vaccine/vpd-int-demand-multicomponent-ed. pdf. Retrieved July 11, 2006.
27. Centers for Disease Control and Prevention. The guide to community preventive services. Effectiveness of requiring vaccinations for child care, school, and college attendance to increase vaccination coverage. Atlanta (GA): CDC; 2003. Available at: http://www.thecommunityguide.org/vaccine/vpd-int- demand-require.pdf. Retrieved July 11, 2006.
28. English A, Kenney KE. State minor consent laws: a summary. 2nd ed. Chapel Hill (NC): Center for Adolescent Health & the Law; 2003.